| Ticker Details |
CorMedix Inc.
Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases.
|
| IPO Date: |
May 13, 2010 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$657.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 4.45%
|
| Avg Daily Range (30 D): |
$0.23 | 2.95%
|
| Avg Daily Range (90 D): |
$0.21 | 2.63%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.67M |
| Avg Daily Volume (30 D): |
1.07M |
| Avg Daily Volume (90 D): |
1.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
192 |
| Avg Trade Size (Sh.) (30 D): |
85 |
| Avg Trade Size (Sh.) (90 D): |
86 |
| Institutional Trades |
| Total Institutional Trades: |
1,078 |
| Avg Institutional Trade: |
$1.43M |
| Avg Institutional Trade (30 D): |
$1.25M |
| Avg Institutional Trade (90 D): |
$1.3M |
| Avg Institutional Trade Volume: |
.14M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.67M |
| Avg Closing Trade (30 D): |
$1.27M |
| Avg Closing Trade (90 D): |
$1.32M |
| Avg Closing Volume: |
180.92K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$2.36
|
$.33
|
$.48
|
|
Diluted EPS
|
$2.05
|
$.29
|
$.43
|
|
Revenue
|
$462.25M
|
$101.93M
|
$127.43M
|
|
Gross Profit
|
$382.64M
|
$77.13M
|
$105.12M
|
|
Net Income / Loss
|
$187.17M
|
$25.99M
|
$38.6M
|
|
Operating Income / Loss
|
$217.04M
|
$42.91M
|
$63.66M
|
|
Cost of Revenue
|
$55.54M
|
$24.81M
|
$12.01M
|
|
Net Cash Flow
|
$98.27M
|
$78.61M
|
$33.25M
|
|
PE Ratio
|
|
|
|
|
|
|
